‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant

‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant

Introductions and Objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the treatment of hepatitis C is historically challenging. The purpose of the current study was t...

Full description

Bibliographic Details
Main Authors: Fabrizio Fabrizi, Cristina Alonso, Ana Palazzo, Margarita Anders, Maria Virginia Reggiardo, Hugo Cheinquer, Maria Grazia Videla Zuain, Sebastian Figueroa, Manuel Mendizabal, Marcelo Silva, Ezequiel Ridruejo
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Annals of Hepatology
Subjects:
Antiviral agents
Chronic kidney disease
Hepatitis C
Kidney transplant
Viral response
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121000363

Internet

http://www.sciencedirect.com/science/article/pii/S1665268121000363

Similar Items